Chemed Stock Analysis, Valuation (NYSE:CHE)
Chemed Analysis Video
View Chemed stock analysis video. This is our CHE analyst opinion covering the buy and sell arguments for CHE stock.
Chemed Corporation Stock Rating (3.4/5)
Our Chemed stock opinion is based on fundamentals of the company. This Chemed stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.
Should you buy CHE stock?
- Chemed's average operating margin of 6.1% was exceptional.
- LTM Net margins were good at 2.1% for Chemed.
- When compared with the Medical-Outpatient-Home care industry average PS ratio of 5, the price-to-sales ratio of 1.9 for CHE stock is attractive.
- Chemed generates a high return on invested capital of 5.5%.
- Chemed has a good Return On Equity (ROE) of 6.9%.
Should you sell CHE stock?
- Revenue growth of 2.9% has been weak over the last 5 years.